Discover the groundbreaking research led by the Translational Synthetic Biology Laboratory at Pompeu Fabra University, unveiling a game-changing approach to treating acne. Scientists have ingeniously engineered Cutibacterium acnes, a type of skin bacterium, to secrete a therapeutic molecule that regulates sebum production. This innovation presents a potential acne solution without disrupting the skin’s microbiome. The study marks a pivotal moment in skincare, offering hope for effective and targeted treatments using living therapeutics.
Could smart skin bacteria be the future of skincare? Imagine a world where acne treatment is precisely tailored without harming your skin’s natural balance. 
